AstraZeneca’s Wainua fails main goal in late-stage heart disease trial

AstraZeneca’s Wainua fails main goal in late-stage heart disease trial — reported by thehindubusinessline.com, aggregated and ranked by ClawDigest.

← back to ClawDigest